| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ya Shao, Tianbo X. A study on the neuroprotective effect of miR-206-3p on Alzheimer's disease mice by regulating brain-derived neurotrophic factor. Annals of translational medicine. vol 10. issue 2. 2022-03-14. PMID:35282109. |
a study on the neuroprotective effect of mir-206-3p on alzheimer's disease mice by regulating brain-derived neurotrophic factor. |
2022-03-14 |
2023-08-13 |
mouse |
| Lina Gao, Yun Zhang, Keenan Sterling, Weihong Son. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. Translational neurodegeneration. vol 11. issue 1. 2022-01-29. PMID:35090576. |
brain-derived neurotrophic factor in alzheimer's disease and its pharmaceutical potential. |
2022-01-29 |
2023-08-13 |
Not clear |
| M Windy McNerney, Alesha Heath, Sindhu Narayanan, Jerome Yesavag. Repetitive Transcranial Magnetic Stimulation Improves Brain-Derived Neurotrophic Factor and Cholinergic Signaling in the 3xTgAD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2022-01-24. PMID:35068462. |
repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xtgad mouse model of alzheimer's disease. |
2022-01-24 |
2023-08-13 |
mouse |
| Shaun Cade, Xin-Fu Zhou, Larisa Bobrovskay. The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease. Reviews in the neurosciences. 2022-01-04. PMID:34982865. |
the role of brain-derived neurotrophic factor and the neurotrophin receptor p75ntr in age-related brain atrophy and the transition to alzheimer's disease. |
2022-01-04 |
2023-08-13 |
Not clear |
| Shaun Cade, Xin-Fu Zhou, Larisa Bobrovskay. The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease. Reviews in the neurosciences. 2022-01-04. PMID:34982865. |
brain derived neurotrophic factor is a neurotrophin expressed in the brain previously implicated in alzheimer's disease due to its involvement in synaptic plasticity. |
2022-01-04 |
2023-08-13 |
Not clear |
| Shaun Cade, Xin-Fu Zhou, Larisa Bobrovskay. The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease. Reviews in the neurosciences. 2022-01-04. PMID:34982865. |
a desirable therapeutic approach for alzheimer's disease is to stimulate the expression of brain derived neurotrophic factor and potentially regenerate lost synapses. |
2022-01-04 |
2023-08-13 |
Not clear |
| Shaun Cade, Xin-Fu Zhou, Larisa Bobrovskay. The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer's disease. Reviews in the neurosciences. 2022-01-04. PMID:34982865. |
this review will evaluate current evidence on how age-related alterations in the synthesis, processing and signalling of brain derived neurotrophic factor may increase the risk of alzheimer's disease. |
2022-01-04 |
2023-08-13 |
Not clear |
| Debora Cutuli, Eugenia Landolfo, Laura Petrosini, Francesca Gelf. Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders. Journal of Alzheimer's disease : JAD. 2021-12-13. PMID:34897089. |
environmental enrichment effects on the brain-derived neurotrophic factor expression in healthy condition, alzheimer's disease, and other neurodegenerative disorders. |
2021-12-13 |
2023-08-13 |
Not clear |
| Stephen R Edwards, Nemat Khan, Elizabeth J Coulson, Maree T Smit. Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's disease. Clinical and experimental pharmacology & physiology. vol 47. issue 10. 2021-10-29. PMID:32542833. |
comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of alzheimer's disease. |
2021-10-29 |
2023-08-13 |
mouse |
| Yu Wang, Yu Feng, Qunying Fu, Lei L. Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression. Experimental and therapeutic medicine. vol 6. issue 3. 2021-10-21. PMID:24137274. |
panax notoginsenoside rb1 ameliorates alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating tau protein expression. |
2021-10-21 |
2023-08-12 |
Not clear |
| Hanan Polansky, Benjamin Gora. How an increase in the copy number of HSV-1 during latency can cause Alzheimer's disease: the viral and cellular dynamics according to the microcompetition model. Journal of neurovirology. 2021-10-12. PMID:34635992. |
third, we describe how an increase in this copy number can reduce the concentration of the nmda receptor subunits nr1 and nr2b (grin1 and grin2b genes), and brain derived neurotrophic factor (bdnf), which can cause an impaired synaptic plasticity, aβ accumulation and eventually alzheimer's disease. |
2021-10-12 |
2023-08-13 |
Not clear |
| Robin M Voigt, Shohreh Raeisi, Jingyun Yang, Sue Leurgans, Christopher B Forsyth, Aron S Buchman, David A Bennett, Ali Keshavarzia. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease. PloS one. vol 16. issue 3. 2021-08-25. PMID:33661922. |
systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident alzheimer's disease. |
2021-08-25 |
2023-08-13 |
Not clear |
| Pragya Girotra, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Simona Bunga. Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer's Disease. Journal of molecular neuroscience : MN. 2021-08-23. PMID:34424488. |
investigation of the molecular role of brain-derived neurotrophic factor in alzheimer's disease. |
2021-08-23 |
2023-08-13 |
Not clear |
| Tadahiro Numakawa, Haruki Odak. Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer's Disease: Beneficial Effects of Flavonoids for Neuroprotection. International journal of molecular sciences. vol 22. issue 11. 2021-06-22. PMID:34071978. |
brain-derived neurotrophic factor signaling in the pathophysiology of alzheimer's disease: beneficial effects of flavonoids for neuroprotection. |
2021-06-22 |
2023-08-13 |
Not clear |
| Lucia Caffino, Francesca Mottarlini, Fabio Fumagall. Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease. CNS drugs. vol 34. issue 3. 2021-06-11. PMID:32052374. |
we focused on the neurotrophin brain-derived neurotrophic factor, providing several lines of evidence pointing to brain-derived neurotrophic factor as a plausible endophenotype of cognitive deficits in alzheimer's disease, illustrating some of the most recent possibilities to modulate the expression of this neurotrophin in the brain in an attempt to ameliorate cognition and delay the progression of alzheimer's disease. |
2021-06-11 |
2023-08-13 |
Not clear |
| Lucia Caffino, Francesca Mottarlini, Fabio Fumagall. Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease. CNS drugs. vol 34. issue 3. 2021-06-11. PMID:32052374. |
this review shows that otherwise disparate pharmacologic or non-pharmacologic approaches converge on brain-derived neurotrophic factor, providing a means whereby apparently unrelated medical approaches may nevertheless produce similar synaptic and cognitive outcomes in alzheimer's disease pathogenesis, suggesting that brain-derived neurotrophic factor-based synaptic repair may represent a modifying strategy to ameliorate cognition in alzheimer's disease. |
2021-06-11 |
2023-08-13 |
Not clear |
| Nozomi Tagai, Ayako Tanaka, Akira Sato, Fumiaki Uchiumi, Sei-Ichi Tanum. Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model. Biological & pharmaceutical bulletin. vol 43. issue 7. 2020-12-31. PMID:32612070. |
low levels of brain-derived neurotrophic factor trigger self-aggregated amyloid β-induced neuronal cell death in an alzheimer's cell model. |
2020-12-31 |
2023-08-13 |
human |
| Ericksen Mielle Borba, Juliana Avila Duarte, Giovana Bristot, Ellen Scotton, Ana Luiza Camozzato, Márcia Lorena Fagundes Chave. Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease. Dementia and geriatric cognitive disorders extra. vol 6. issue 3. 2020-10-01. PMID:28101102. |
brain-derived neurotrophic factor serum levels and hippocampal volume in mild cognitive impairment and dementia due to alzheimer disease. |
2020-10-01 |
2023-08-13 |
Not clear |
| Alicia Martin, Jordan Stillman, Maria-Jose Miguez, H Reginald McDaniel, Janet Konefal, Judi M Woolger, John E Lewi. The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia. Journal of clinical and translational research. vol 3. issue 3. 2020-10-01. PMID:30895275. |
the effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in alzheimer's dementia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Lievyn Enette, Thomas Vogel, Sylvie Merle, Anna-Gaelle Valard-Guiguet, Nathalie Ozier-Lafontaine, Remi Neviere, Claudia Leuly-Joncart, Jean Luc Fanon, Pierre Olivier Lan. Effect of 9 weeks continuous vs. interval aerobic training on plasma BDNF levels, aerobic fitness, cognitive capacity and quality of life among seniors with mild to moderate Alzheimer's disease: a randomized controlled trial. European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity. vol 17. 2020-09-30. PMID:31921371. |
this study aims to compare the effect of 9-weeks continuous (cat) to interval aerobic training (iat) on brain derived neurotrophic factor (bdnf) plasma level, aerobic fitness, cognitive performance, and quality of life among senior with alzheimer's disease (ad). |
2020-09-30 |
2023-08-13 |
cat |